PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Trends Analyst Outlook Journalist POV

37 hedge funds and large institutions have $58.4M invested in Protalix BioTherapeutics in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

60% less call options, than puts

Call options by funds: $43K | Put options by funds: $108K

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$43K
Puts
$108K
Net Calls
Net Calls Change

Top Buyers

1
+$1.01M
2
+$168K
3
+$92.5K
4
Simplex Trading
Simplex Trading
Illinois
+$39.6K
5
NCCM
Nine Chapters Capital Management
New Jersey
+$27K

Top Sellers

1
-$3.68M
2
-$1.55M
3
-$525K
4
GPP
Great Point Partners
Connecticut
-$392K
5
DCM
DAFNA Capital Management
California
-$273K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$28K
27
$27K
28
$27K
29
$27K
30
$25K
31
$20K
32
$9K
33
$9K
34
$5K
35
$4K
36
$1K
37
$6
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2